Save 10% off your first order | Limited time offer | Create your account now

Downloads

COA COO

Daunorubicin Impurity C (Mix.of Diastereomers)

Impurity

CAS Number

79438-97-4

Molecular Formula

C28H31NO10

Product format

Neat

Molecular Weight

541.56

API Family

Daunorubicin

Synonyms

Feudomycin B; SV8FPE7YP7; 79438-97-4; RefChem:921591; 5, 12-Naphthacenedione, 10-((3-amino-2, 3, 6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7, 8, 9, 10-tetrahydro-6, 8, 11-trihydroxy-1-methoxy-8-(2-oxopropyl)-, (8S-cis)-; Daunorubicin EP Impurity C; (8S, 10S)-10-(((2R, 4S, 5S, 6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6, 8, 11-trihydroxy-1-methoxy-8-(2-oxopropyl)-7, 8, 9, 10-tetrahydrotetracene-5, 12-dione; Doxorubicinol Impurity 5; HY-142058; DAUNORUBICIN HYDROCHLORIDE IMPURITY C [EP IMPURITY]; (7S, 9S)-7-[(2R, 4S, 5S, 6S)-4-Amino-5-hydroxy-6-methyloxan-2-yl]oxy-6, 9, 11-trihydroxy-4-methoxy-9-(2-oxopropyl)-8, 10-dihydro-7H-tetracene-5, 12-dione; (8S, 10S)-10-((3-AMINO-2, 3, 6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-6, 8, 11-TRIHYDROXY-1-METHOXY-8-(2-OXOPROPYL)-7, 8, 9, 10-TETRAHYDROTETRACENE-5 and 12-DIONE

Iupac Name

(7S, 9S)-7-[(2R, 4S, 5S, 6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6, 9, 11-trihydroxy-4-methoxy-9-(2-oxopropyl)-8, 10-dihydro-7H-tetracene-5 and 12-dione

InChI

InChI=1S/C28H31NO10/c1-11(30)8-28(36)9-14-20(17(10-28)39-18-7-15(29)23(31)12(2)38-18)27(35)22-21(25(14)33)24(32)13-5-4-6-16(37-3)19(13)26(22)34/h4-6,12,15,17-18,23,31,33,35-36H,7-10,29H2,1-3H3/t12-,15-,17-,18-,23+,28-/m0/s1

Downloads

COA COO

Available products

Pack Size SKU
Category Expected Delivery Price Quantity

To inquire

To inquire

To inquire

Request custom package size
Product added to your cart

Product Type

Custom
Synthesis

We offer tailor-made synthesis services of up to gram-quantities of materials for a wide range of pharmaceutical customers. The customer can order a specific molecule that is only synthesized on your request on the scale, with the purity and with the specification or methods you require.

Read more